Oct 02, 2023 / 05:00PM GMT
Geulah Livshits - Chardan Capital Markets, LLC - Analyst
Pleasure to introduce our next guest, Dr. Steven Kelly, President and CEO of Carisma Therapeutics. The format for this session is a fireside chat. And so thank you for joining us today.
Steven Kelly - Carisma Therapeutics Inc. - President & CEO
My pleasure.
Questions and Answers:
Geulah Livshits - Chardan Capital Markets, LLC - AnalystYeah. So to start with, can you give us a high-level overview of Carisma and walk us through the key catalysts that we should anticipate over the next year? And then we'll talk about the programs in more detail.
Steven Kelly - Carisma Therapeutics Inc. - President & CEO
Yeah, absolutely. So Carisma is about a seven-year old company, Penn spin out. And the idea behind it is that the macrophage is an incredibly powerful cell. And so we put our efforts into how do we harness that power and drive it to treat patients with devastating disease like cancer, liver fibrosis, et
Trustpilot
